Oracle CapEx decreased by 6.4% to $8.50B in Q2 2025 compared to the prior quarter. Year-over-year, this metric grew by 269.2%, from $2.30B to $8.50B.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q4 '21 | Q1 '22 | Q2 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $717.00M | $1.06B | $3.09B | $1.42B | $1.72B | $675.00M | $4.39B | $1.91B | $1.31B | $4.96B | $2.80B | $2.30B | $18.23B | $9.08B | $8.50B |
| QoQ Change | — | +48.1% | +191.1% | -54.0% | +20.8% | -60.7% | +550.1% | -56.4% | -31.3% | +277.4% | -43.6% | -17.7% | +691.7% | -50.2% | -6.4% |
| YoY Change | — | — | — | +98.5% | +61.9% | -78.2% | — | +34.4% | -23.6% | +634.7% | +46.3% | +75.3% | +267.7% | +224.5% | +269.2% |